MEK1 mutations confer resistance to MEK and B-RAF inhibition
CM Emery, KG Vijayendran… - Proceedings of the …, 2009 - National Acad Sciences
Genetic alterations that activate the mitogen-activated protein kinase (MAP kinase) pathway
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
MEK1 mutations confer resistance to MEK and B-RAF inhibition
CM Emery, KG Vijayendran, MC Zipser… - Proceedings of the …, 2009 - ui.adsabs.harvard.edu
Genetic alterations that activate the mitogen-activated protein kinase (MAP kinase) pathway
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
MEK1 Mutations Confer Resistance to MEK and B-RAF Inhibition
CM Emery, KG Vijayendran, MC Zipser… - Proceedings of the …, 2009 - JSTOR
Genetic alterations that activate the mitogen-activated protein kinase (MAP kinase) pathway
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
MEK1 mutations confer resistance to MEK and B-RAF inhibition.
CM Emery, KG Vijayendran, MC Zipser… - Proceedings of the …, 2009 - europepmc.org
Genetic alterations that activate the mitogen-activated protein kinase (MAP kinase) pathway
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
[HTML][HTML] MEK1 mutations confer resistance to MEK and B-RAF inhibition
CM Emery, KG Vijayendran, MC Zipser… - Proceedings of the …, 2009 - ncbi.nlm.nih.gov
Genetic alterations that activate the mitogen-activated protein kinase (MAP kinase) pathway
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
[PDF][PDF] MEK1 mutations confer resistance to MEK and B-RAF inhibition
CM Emerya, KG Vijayendrana, MC Zipserc… - PNAS, 2009 - academia.edu
Results Comprehensive Identification of MEK1 Resistance Mutations in Vitro. To begin to
characterize resistance to MAP kinase pathway inhibition in the context of BRAFV600E …
characterize resistance to MAP kinase pathway inhibition in the context of BRAFV600E …
MEK1 mutations confer resistance to MEK and B-RAF inhibition
CM Emery, KG Vijayendran… - Proceedings of the …, 2009 - pubmed.ncbi.nlm.nih.gov
Genetic alterations that activate the mitogen-activated protein kinase (MAP kinase) pathway
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
occur commonly in cancer. For example, the majority of melanomas harbor mutations in the …
MEK1 mutations confer resistance to MEK and B-RAF inhibition
CM Emery, KG Vijayendran, MC Zipser… - Proceedings of the …, 2009 - cir.nii.ac.jp
抄録< jats: p> Genetic alterations that activate the mitogen-activated protein kinase (MAP
kinase) pathway occur commonly in cancer. For example, the majority of melanomas harbor …
kinase) pathway occur commonly in cancer. For example, the majority of melanomas harbor …